Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07822451
NA

Topical Nasal Moisturization for Oxygen-Related Nasal Dryness During Low-Flow Oxygen Therapy

Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

View on ClinicalTrials.gov

Summary

Conventional low-flow oxygen therapy delivered through a nasal cannula can cause nasal dryness and discomfort. This study evaluated whether topical nasal moisturization with 0.9% isotonic saline nasal drops or a hyaluronic acid-based nasal spray could reduce nasal dryness in adults receiving low-flow oxygen therapy. In this prospective, randomized, three-arm clinical trial, 150 adults receiving conventional low-flow nasal oxygen therapy in a coronary intensive care unit were assigned to one of three groups: low-flow oxygen alone, low-flow oxygen plus 0.9% isotonic saline nasal drops, or low-flow oxygen plus a hyaluronic acid-based nasal spray. All participants received low-flow oxygen alone during the first 4 hours. After the 4-hour assessment, the assigned topical nasal interventions were started and continued until the 12-hour assessment. The primary outcome was patient-reported nasal dryness. Other assessments included patient comfort, nasal pain, clinician-assessed nasal mucosal dryness, nasal moisture measured using the intranasal Schirmer test, and epistaxis. Outcomes were assessed at 4 and 12 hours.

Official title: Topical Nasal Moisturization for Oxygen-Induced Nasal Dryness During Conventional Low-Flow Oxygen Therapy: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2026-07-29

Completion Date

2026-08-30

Last Updated

2026-09-16

Healthy Volunteers

No

Interventions

OTHER

Conventional Low-Flow Oxygen Therapy

Conventional low-flow oxygen therapy was administered via a standard nasal cannula according to the treating physician's clinical judgment and routine coronary intensive care practice.

DRUG

0.9% Isotonic Saline Nasal Drops

Participants received topical nasal moisturization with 0.9% isotonic saline nasal drops in addition to conventional low-flow oxygen therapy. The nasal drops were administered after the 4-hour pre-intervention assessment and repeated at 7 and 10 hours. Final outcome assessment was performed at 12 hours.

DRUG

Hyaluronic Acid-Based Nasal Spray

Participants received topical nasal moisturization with a hyaluronic acid-based nasal spray (Hylonem®) containing sodium hyaluronate, sodium chloride, grapefruit seed extract, and purified water, in addition to conventional low-flow oxygen therapy. The nasal spray was administered after the 4-hour pre-intervention assessment. Final outcome assessment was performed at 12 hours.

Locations (1)

Sultan Abdulhamid Han Training and Research Hospital

Istanbul, Istanbul, Turkey (Türkiye)